Dataset: PRC2 in Ewing tumors
We found the PRC2 component EZH2 to be upregulated by the pathognomonic fusion oncogene EWS-FLI1 in Ewing tumors and mesenchymal stem...
We found the PRC2 component EZH2 to be upregulated by the pathognomonic fusion oncogene EWS-FLI1 in Ewing tumors and mesenchymal stem cells (Richter GH et al., Proc Natl Acad Sci U S A. 2009;106:5324-9). Downregulation of EZH2 by RNA interference in Ewing tumor cell lines suppressed oncogenic transformation in vitro and in vivo. These data suggest that EZH2 might play a central role in Ewing Tumor pathology. RNA from tumor samples was isolated with Trizol and subjected to microarray analysis using HG_U133A microarrays following the Affymetrix protocol. Ewing tumors vs. neuroblastoma controls
- Species:
- human
- Samples:
- 9
- Source:
- E-GEOD-15757
- PubMed:
- 19502792
- Updated:
- Jan.17, 2015
- Registered:
- Jan.17, 2015
Factors:
(via ArrayExpress)
Sample | TUMOR TYPE | STAGE |
---|---|---|
GSM395600 1 | Ewing tumor | not specified |
GSM395601 1 | Ewing tumor | not specified |
GSM395602 1 | Ewing tumor | not specified |
GSM395603 1 | Ewing tumor | not specified |
GSM398822 1 | neuroblastoma | IV |
GSM398823 1 | neuroblastoma | I |
GSM398824 1 | neuroblastoma | III |
GSM398825 1 | neuroblastoma | I |
GSM398826 1 | neuroblastoma | III |